Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Call For Papers

Special Issue on Breast Cancer


Breast Cancer, which is the most common invasive cancer in women, caused 458,503 deaths worldwide in 2008. It is a type of cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules. The primary risk factors for breast cancer are female sex, older age and genetics. It is usually treated with surgery, which may be followed by chemotherapy or radiation therapy. Women may reduce their risk of breast cancer by maintaining a healthy weight, drinking less alcohol, breastfeeding their children and so on. As the high mortality of Breast Cancer, close attention and further research shows significant importance.

 

In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on exploring breast cancer. Potential topics include, but are not limited to:

 


  • Classification of breast cancer      
  • Signs and symptoms      
  • Epidemiology      
  • Pathophysiology      
  • Diet and lifestyle      
  • Relapse and risk factors      
  • Diagnosis and screening      
  • Prevention and treatment


 

Authors should read over the journal’s Authors’ Guidelines carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.

 

Please kindly notice that the “Special Issue” under your manuscript title is supposed to be specified and the research field “Special Issue - Breast Cancer” should be chosen during your submission.

 

According to the following timetable:

 

Submission Deadline

July 30th, 2015

Publication Date

September 2015

 

Guest Editor:

 

 

 

For further questions or inquiries

Please contact Editorial Assistant at

jct@scirp.org   

Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top